Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Familial porphyria cutanea tarda
|
6 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.700 | 0 | |||||||
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7 (finding)
|
2 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.700 | 0 | |||||||
TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2
|
2 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.700 | 0 | |||||||
Hereditary hemochromatosis
|
56 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.800 | 0.991 | 114 | 1996 | 2019 | ||||
HEMOCHROMATOSIS, TYPE 1
|
62 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.800 | 0.960 | 99 | 1996 | 2019 | ||||
Iron Overload
|
53 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.100 | 0.886 | 79 | 1997 | 2019 | ||||
Hemochromatosis
|
45 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.100 | 0.961 | 77 | 1997 | 2019 | ||||
Porphyria Cutanea Tarda
|
39 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.100 | 0.909 | 11 | 1998 | 2014 | ||||
Coronary heart disease
|
1178 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.060 | 1.000 | 6 | 1998 | 2013 | ||||
Arteriosclerosis
|
267 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.040 | 1.000 | 4 | 1998 | 2019 | ||||
Atherosclerosis
|
281 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.040 | 1.000 | 4 | 1998 | 2019 | ||||
Siderosis
|
2 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.030 | 1.000 | 3 | 1998 | 2010 | ||||
Cardiomyopathies
|
294 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||
Liver diseases
|
100 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.100 | 0.818 | 11 | 1999 | 2011 | ||||
Hepatitis C, Chronic
|
80 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.080 | 0.875 | 8 | 1999 | 2010 | ||||
Hypocalciuric hypercalcemia, familial, type 1
|
58 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.070 | 1.000 | 7 | 1999 | 2002 | ||||
Fatty Liver Disease
|
81 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.050 | 1.000 | 5 | 1999 | 2012 | ||||
Alcoholic Liver Diseases
|
20 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.020 | 1.000 | 2 | 1999 | 2001 | ||||
Chronic active hepatitis
|
34 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.010 | 1.000 | 1 | 1999 | 1999 | ||||
Hyperlipidemia
|
83 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.010 | 1.000 | 1 | 1999 | 1999 | ||||
Multiple Chronic Conditions
|
42 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.010 | 1.000 | 1 | 1999 | 1999 | ||||
Secondary acquired sideroblastic anemia
|
2 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.010 | 1.000 | 1 | 1999 | 1999 | ||||
Sideroblastic anemia
|
11 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.010 | 1 | 1999 | 1999 | |||||
Variegate Porphyria
|
24 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.710 | 1.000 | 1 | 1999 | 1999 | ||||
Hepatitis C
|
347 | 0.452 | 0.760 | 6 | 26090951 | missense variant | C/G;T | snv | 0.11 | 0.10 | 0.100 | 0.929 | 14 | 2000 | 2010 |